The Risks and Realities of Commercial Drug Importation

Published 2019

This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013. Based on expert interviews, literature reviews and quantitative data modeling, the report analyzes policies for their commercial feasibility, operational costs to the supply chain and overall effects on patient safety.

Enter your name and email address to download the publication: